{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:21:22Z","timestamp":1690356082136},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T00:00:00Z","timestamp":1265328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1477-7819-8-8","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T19:15:07Z","timestamp":1265397307000},"source":"Crossref","is-referenced-by-count":2,"title":["Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer"],"prefix":"10.1186","volume":"8","author":[{"given":"Ferdinando","family":"Riccardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Buonerba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guglielmo","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimma","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Scagliarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florinda","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Carteni'","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,5]]},"reference":[{"issue":"Suppl","key":"647_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1378\/chest.103.1_Supplement.43S","volume":"103","author":"KS Albain","year":"1993","unstructured":"Albain KS: Induction therapy followed by definitive local control for stage III non-small-cell lung cancer. A review, with a focus on recent trimodality trials. Chest. 1993, 103 (Suppl): 43-50S. 10.1378\/chest.103.1_Supplement.43S.","journal-title":"Chest"},{"issue":"5 Suppl","key":"647_CR2","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/01.JTO.0000268640.56073.d1","volume":"2","author":"W Eberhardt","year":"2007","unstructured":"Eberhardt W, Gauler T, P\u00f6ttgen C, Krbek T, Korfee S, Stamatis G, Stuschke M: Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer. J Thorac Oncol. 2007, 2 (5 Suppl): S35-6. 10.1097\/01.JTO.0000268640.56073.d1.","journal-title":"J Thorac Oncol"},{"key":"647_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1200\/JCO.20.1.247","volume":"20","author":"A Depierre","year":"2002","unstructured":"Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemari\u00e9 E, Gouva S, Paillot N, Br\u00e9chot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monch\u00e2tre M, Co\u00ebtmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C, French Thoracic Cooperative Group: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol. 2002, 20: 247-53. 10.1200\/JCO.20.1.247.","journal-title":"J Clin Oncol"},{"key":"647_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jama.292.4.470","volume":"292","author":"C Delbaldo","year":"2004","unstructured":"Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP: Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis. JAMA. 2004, 292: 470-84. 10.1001\/jama.292.4.470.","journal-title":"JAMA"},{"key":"647_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/annonc\/mdg009","volume":"14","author":"KV Mattson","year":"2003","unstructured":"Mattson KV, Abratt RP, ten Velde G, Krofta K: Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. Ann Oncol. 2003, 14: 116-22. 10.1093\/annonc\/mdg009.","journal-title":"Ann Oncol"},{"key":"647_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3816\/CLC.2003.n.008","volume":"4","author":"V Georgoulias","year":"2003","unstructured":"Georgoulias V, Pallis AG, Kourousis C, Alexopoulos A, Ardavanis A, Agelidou A, Agelidou M, Toumbis M, Tzannes S, Pavlakou G, Ziotopoulos P, Tzelepatiotis E, Samaras N: Docetaxel versus docetaxel\/cisplatin in patients with advanced non-small-cell lung cancer: preliminary analysis of a multicenter, randomized phase III study. Clin Lung Cancer. 2003, 4: 288-93. 10.3816\/CLC.2003.n.008.","journal-title":"Clin Lung Cancer"},{"key":"647_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1200\/JCO.2005.07.172","volume":"23","author":"RC Lilenbaum","year":"2005","unstructured":"Lilenbaum RC, Herndon JE, List MA, Desch C, Watson DM, Miller AA, Graziano SL, Perry MC, Saville W, Chahinian P, Weeks JC, Holland JC, Green MR: Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol. 2005, 23: 190-6. 10.1200\/JCO.2005.07.172.","journal-title":"J Clin Oncol"},{"key":"647_CR8","doi-asserted-by":"crossref","unstructured":"Heys SD, Hutcheon AW, Sarkar TK, Ogston KN, Miller ID, Payne S, Smith I, Walker LG, Eremin O: Aberdeen Breast Group. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clin Breast Cancer. 2002, S69-74. 10.3816\/CBC.2002.s.015. Suppl","DOI":"10.3816\/CBC.2002.s.015"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-8-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7819-8-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-8-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T09:32:40Z","timestamp":1548149560000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-8-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,5]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-8-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,5]]},"article-number":"8"}}